CRAMS Outpace Generics Makers 5-1 On India Stock Market (India)
This article was originally published in PharmAsia News
Executive Summary
Contract research and manufacturing services in India are outperforming pharmaceutical generics makers by 5-1 on the country's stock exchange, Sensex. Shares of generics companies grew by 4 percent in the past three months while those of CRAMS increased by 19 percent. An analyst ascribed the difference to the CRAMS segment seeing "better revenues visibility" than the generics, hit hard by pricing pressures around the world. (Click here for more